0000899243-16-012641.txt : 20160203
0000899243-16-012641.hdr.sgml : 20160203
20160203170025
ACCESSION NUMBER: 0000899243-16-012641
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160201
FILED AS OF DATE: 20160203
DATE AS OF CHANGE: 20160203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seres Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274326290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 440
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 945 9626
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 440
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Seres Health, Inc.
DATE OF NAME CHANGE: 20140603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shaff Eric D.
CENTRAL INDEX KEY: 0001643734
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37465
FILM NUMBER: 161385556
MAIL ADDRESS:
STREET 1: C/O SERES HEALTH, INC.
STREET 2: 161 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-02-01
0
0001609809
Seres Therapeutics, Inc.
MCRB
0001643734
Shaff Eric D.
C/O SERES THERAPEUTICS, INC.
215 FIRST STREET
CAMBRIDGE
MA
02142
0
1
0
0
CFO and EVP
Stock Option (Right to Buy)
26.20
2016-02-01
4
A
0
78500
0.00
A
2026-01-31
Common Stock
78500
78500
D
The option vests as to 25% of the shares subject to the option on February 1, 2017, and as to an additional 6.25% of the total number of shares subject to the option upon the completion of each three consecutive months of service thereafter.
/s/ Eric D. Shaff
2016-02-03